Gene · 9507
Papers2,479
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 2,479
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tracing the SARS-CoV-2 infection on the ocular surface: Overview and preliminary corneoscleral transcriptome sequencing. | Exp Eye Res | 2022 | 35134391 | PubTator, text mining | PubMed |
Fumitremorgin C alleviates advanced glycation end products (AGE)-induced chondrocyte inflammation and collagen II and aggrecan degradation through sirtuin-1 (SIRT1)/nuclear factor (NF)-κB/ mitogen-activated protein kinase (MAPK). | Bioengineered | 2022 | 35109750 | PubTator, text mining | PubMed |
| Opportunities for Expanding Encoded Chemical Diversification and Improving Hit Enrichment in mRNA-Displayed Peptide Libraries. | Chembiochem | 2022 | 35100479 | PubTator, text mining | PubMed |
| LncRNA nuclear receptor subfamily 2 group F member 1 antisense RNA 1 (NR2F1-AS1) aggravates nucleus pulposus cell apoptosis and extracellular matrix degradation. | Bioengineered | 2022 | 35094651 | PubTator, text mining | PubMed |
| Cartilage tissue engineering: From proinflammatory and anti‑inflammatory cytokines to osteoarthritis treatments (Review). | Mol Med Rep | 2022 | 35088882 | PubTator, text mining | PubMed |
| Biome-microbiome interactions in peri-implantitis: A pilot investigation. | J Periodontol | 2022 | 35073418 | PubTator, text mining | PubMed |
| tRF3008A suppresses the progression and metastasis of colorectal cancer by destabilizing FOXK1 in an AGO-dependent manner. | J Exp Clin Cancer Res | 2022 | 35065674 | PubTator, text mining | PubMed |
| The Role of ADAMTS-4 in Atherosclerosis and Vessel Wall Abnormalities. | J Vasc Res | 2022 | 35051931 | PubTator, text mining | PubMed |
| Pathogenesis of glaucoma: Extracellular matrix dysfunction in the trabecular meshwork-A review. | Clin Exp Ophthalmol | 2022 | 35037377 | PubTator, text mining | PubMed |
| Aloin Regulates Matrix Metabolism and Apoptosis in Human Nucleus Pulposus Cells via the TAK1/NF-κB/NLRP3 Signaling Pathway. | Stem Cells Int | 2022 | 35035490 | PubTator, text mining | PubMed |
| Injectable recombinant block polymer gel for sustained delivery of therapeutic protein in post traumatic osteoarthritis. | Biomaterials | 2022 | 35032910 | PubTator, text mining | PubMed |
| The essential anti-angiogenic strategies in cartilage engineering and osteoarthritic cartilage repair. | Cell Mol Life Sci | 2022 | 35029764 | PubTator, text mining | PubMed |
| The protective effects of Olmesartan against interleukin-29 (IL-29)-induced type 2 collagen degradation in human chondrocytes. | Bioengineered | 2022 | 35012432 | PubTator, text mining | PubMed |
| Instructive cartilage regeneration modalities with advanced therapeutic implantations under abnormal conditions. | Bioact Mater | 2022 | 34977434 | PubTator, text mining | PubMed |
| Genomics and Functional Genomics of Alzheimer's Disease. | Neurotherapeutics | 2022 | 34935119 | PubTator, text mining | PubMed |
| Development of a Personalized Intestinal Fibrosis Model Using Human Intestinal Organoids Derived From Induced Pluripotent Stem Cells. | Inflamm Bowel Dis | 2022 | 34918082 | PubTator, text mining | PubMed |
| Comparison of ADAMTS Levels in Pulp Tissue Samples of Healthy and Symptomatic Irreversible Pulpitis Teeth. | J Endod | 2022 | 34914940 | PubTator, text mining | PubMed |
| In situ analysis of variations of arsenicals, microbiome and transcriptome profiles along murine intestinal tract. | J Hazard Mater | 2022 | 34876320 | PubTator, text mining | PubMed |
| Microcystin-leucine arginine exposure induced intestinal lipid accumulation and MC-LR efflux disorder in Lithobates catesbeianus tadpoles. | Toxicology | 2022 | 34863901 | PubTator, text mining | PubMed |
| Safety, Pharmacokinetics, and Pharmacodynamics of the ADAMTS-5 Inhibitor GLPG1972/S201086 in Healthy Volunteers and Participants With Osteoarthritis of the Knee or Hip. | Clin Pharmacol Drug Dev | 2022 | 34859612 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9507/papers?page=31